AI Eye-tracking Brain Health Screening Device

AI + eye-tracking + digital biomarkers, completing intelligent brain health risk screening in 5 minutes

AI Eye-tracking Brain Health Screening Device

Core Features

Non-invasive Detection

Non-invasive and contactless, safe and comfortable

Simple and Convenient Operation

One-click start, intelligent guidance

All Age Groups Covered

Suitable for children, adults, and seniors, with broad applicability

Rapid Deployment in Multiple Scenarios

Flexibly adapts to hospitals, schools, rehabilitation centers, etc.

Three Major AI Intelligent Screening Directions

Covers all age groups including children, adults, and seniors; AI + eye-tracking + digital biomarkers precisely identify brain health risks

ASD

ASD Artificial Intelligence Screening

Applicable Age: 3-12 years
87%
Sensitivity
84%
Specificity
Dual Mode
1-min quick screening + 5-min precise testing
Detection Dimensions
Social Attention LevelFace Recognition AccuracySocial Cognitive AbilityEmotion Recognition Ability
Application Scenarios
Children's HospitalsMaternal and Child Health Care CentersRemote Screening PointsPediatric Rehabilitation Centers

Dual-mode screening: 1-minute quick screening + 5-minute precise testing, fully automated AI analysis throughout, efficient and reliable.

AD

Intelligent Screening for Anxiety and Depression Risks

Applicable Age: 13-59 years
Anxiety
Risk Assessment
Depression
Risk Assessment
Stress
Mental State Assessment
Detection Dimensions
Emotional Attention BiasAttention Control AbilityStress Response CharacteristicsEmotion Regulation Ability
Application Scenarios
Corporate EAP ServicesUniversitiesPsychological ClinicsHealth Management Center

Identifies emotional risks based on eye-tracking digital biomarkers, suitable for early mental health screening in adolescents and adults.

MCI

Intelligent Screening for MCI Cognitive Risk

Applicable Age: 60+ years
Early Detection
Risk of Cognitive Decline
Assisted Identification
Mild Cognitive Impairment (MCI)
Long-term
Dynamic Health Tracking
Detection Dimensions
Sustained AttentionExecutive FunctionVisual MemoryInformation Processing Ability
Application Scenarios
Neurology DepartmentGeriatrics DepartmentMemory ClinicCommunity Elderly Care Institutions

Detects the risk of cognitive decline early, assists in identifying Mild Cognitive Impairment (MCI), and supports long-term dynamic health tracking.

Eye-Tracking and Brain Function Testing Workflow

Four-step automated process from viewing task videos to generating risk reports

01

Subject

View task video and record

Natural viewing, no complex operations required
02

Eye Tracker

Collect eye-tracking trajectory data

Non-contact high-precision collection
03

AI Analysis Platform

AI intelligent analysis and processing

Feature Extraction | Model Computation
04

Smart Report

Output risk report

Risks such as ASD/MCI/Anxiety/Depression

AI Intelligent Screening Report

The report includes three modules: risk level, core indicators, and executive function, supporting multi-test comparison and efficacy tracking.

🛡️

Risk Level

Low / Medium / High risk classification, intuitively presenting screening results

📊

Core Indicators

Quantitative analysis of key cognitive dimensions such as attention/memory, benchmarked against reference ranges

📈

Executive Function and Trends

Emotional state trend analysis, supporting multi-session comparison and efficacy tracking

AI-Powered Screening Report - Test Results and Interpretation
AI-Powered Screening Report - Digital Reading Test
AI-Powered Screening Report - Metric Analysis
AI-Powered Screening Report - Report Interpretation

Making screening simpler

Three key areas: ASD / anxiety and depression / MCI; non-contact eye-tracking screening completed in 5 minutes